231 related articles for article (PubMed ID: 22567098)
1. Do anti-angiogenic VEGF (VEGFxxxb) isoforms exist? A cautionary tale.
Harris S; Craze M; Newton J; Fisher M; Shima DT; Tozer GM; Kanthou C
PLoS One; 2012; 7(5):e35231. PubMed ID: 22567098
[TBL] [Abstract][Full Text] [Related]
2. Expression of pro- and anti-angiogenic isoforms of VEGF in the mouse model of oxygen-induced retinopathy.
Zhao M; Shi X; Liang J; Miao Y; Xie W; Zhang Y; Li X
Exp Eye Res; 2011 Dec; 93(6):921-6. PubMed ID: 22067127
[TBL] [Abstract][Full Text] [Related]
3. The endogenous anti-angiogenic family of splice variants of VEGF, VEGFxxxb, are down-regulated in pre-eclamptic placentae at term.
Bates DO; MacMillan PP; Manjaly JG; Qiu Y; Hudson SJ; Bevan HS; Hunter AJ; Soothill PW; Read M; Donaldson LF; Harper SJ
Clin Sci (Lond); 2006 May; 110(5):575-85. PubMed ID: 16451124
[TBL] [Abstract][Full Text] [Related]
4. Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors.
Nowak DG; Woolard J; Amin EM; Konopatskaya O; Saleem MA; Churchill AJ; Ladomery MR; Harper SJ; Bates DO
J Cell Sci; 2008 Oct; 121(Pt 20):3487-95. PubMed ID: 18843117
[TBL] [Abstract][Full Text] [Related]
5. VEGF111b, a new member of VEGFxxxb isoforms and induced by mitomycin C, inhibits angiogenesis.
Gu F; Li X; Kong J; Pan B; Sun M; Zheng L; Yao Y
Biochem Biophys Res Commun; 2013 Nov; 441(1):18-24. PubMed ID: 24125722
[TBL] [Abstract][Full Text] [Related]
6. VEGF
Boudria A; Abou Faycal C; Jia T; Gout S; Keramidas M; Didier C; Lemaître N; Manet S; Coll JL; Toffart AC; Moro-Sibilot D; Albiges-Rizo C; Josserand V; Faurobert E; Brambilla C; Brambilla E; Gazzeri S; Eymin B
Oncogene; 2019 Feb; 38(7):1050-1066. PubMed ID: 30194450
[TBL] [Abstract][Full Text] [Related]
7. Tumour cells expressing single VEGF isoforms display distinct growth, survival and migration characteristics.
Kanthou C; Dachs GU; Lefley DV; Steele AJ; Coralli-Foxon C; Harris S; Greco O; Dos Santos SA; Reyes-Aldasoro CC; English WR; Tozer GM
PLoS One; 2014; 9(8):e104015. PubMed ID: 25119572
[TBL] [Abstract][Full Text] [Related]
8. Blood vessel maturation and response to vascular-disrupting therapy in single vascular endothelial growth factor-A isoform-producing tumors.
Tozer GM; Akerman S; Cross NA; Barber PR; Björndahl MA; Greco O; Harris S; Hill SA; Honess DJ; Ireson CR; Pettyjohn KL; Prise VE; Reyes-Aldasoro CC; Ruhrberg C; Shima DT; Kanthou C
Cancer Res; 2008 Apr; 68(7):2301-11. PubMed ID: 18381437
[TBL] [Abstract][Full Text] [Related]
9. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
Stalmans I
Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
[TBL] [Abstract][Full Text] [Related]
10. The alternatively spliced anti-angiogenic family of VEGF isoforms VEGFxxxb in human kidney development.
Bevan HS; van den Akker NM; Qiu Y; Polman JA; Foster RR; Yem J; Nishikawa A; Satchell SC; Harper SJ; Gittenberger-de Groot AC; Bates DO
Nephron Physiol; 2008; 110(4):p57-67. PubMed ID: 19039247
[TBL] [Abstract][Full Text] [Related]
11. Comparative insight into expression of recombinant human VEGF111b, a newly identified anti-angiogenic isoform, in eukaryotic cell lines.
Dehghanian F; Hojati Z
Gene; 2014 Dec; 553(1):57-62. PubMed ID: 25284510
[TBL] [Abstract][Full Text] [Related]
12. Characterization and differential expression of vascular endothelial growth factor isoforms and receptors in swine corpus luteum throughout estrous cycle.
Ribeiro LA; Bacci ML; Seren E; Tamanini C; Forni M
Mol Reprod Dev; 2007 Feb; 74(2):163-71. PubMed ID: 16967516
[TBL] [Abstract][Full Text] [Related]
13. The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice.
Rennel E; Waine E; Guan H; Schüler Y; Leenders W; Woolard J; Sugiono M; Gillatt D; Kleinerman E; Bates D; Harper S
Br J Cancer; 2008 Apr; 98(7):1250-7. PubMed ID: 18349828
[TBL] [Abstract][Full Text] [Related]
14. Detection of VEGF-A(xxx)b isoforms in human tissues.
Bates DO; Mavrou A; Qiu Y; Carter JG; Hamdollah-Zadeh M; Barratt S; Gammons MV; Millar AB; Salmon AH; Oltean S; Harper SJ
PLoS One; 2013; 8(7):e68399. PubMed ID: 23935865
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of neovascularization and expression shift of pro-/anti-angiogenic vascular endothelial growth factor isoforms after intravitreal bevacizumab injection in oxygen-induced-retinopathy mouse model.
Shi X; Zhao M; Xie WK; Liang JH; Miao YF; DU W; Li XX
Chin Med J (Engl); 2013 Jan; 126(2):345-52. PubMed ID: 23324288
[TBL] [Abstract][Full Text] [Related]
16. VEGF111b, a C-terminal splice variant of VEGF-A and induced by mitomycin C, inhibits ovarian cancer growth.
Li X; Gu F; Niu C; Wang Y; Liu Z; Li N; Pan B; He D; Kong J; Zhang S; Wang X; Yao Y; Zheng L
J Transl Med; 2015 May; 13():164. PubMed ID: 25990504
[TBL] [Abstract][Full Text] [Related]
17. VEGF isoforms and their expression after a single episode of hypoxia or repeated fluctuations between hyperoxia and hypoxia: relevance to clinical ROP.
McColm JR; Geisen P; Hartnett ME
Mol Vis; 2004 Jul; 10():512-20. PubMed ID: 15303088
[TBL] [Abstract][Full Text] [Related]
18. Targeting the pro-angiogenic forms of VEGF or inhibiting their expression as anti-cancer strategies.
Guyot M; Hilmi C; Ambrosetti D; Merlano M; Lo Nigro C; Durivault J; Grépin R; Pagès G
Oncotarget; 2017 Feb; 8(6):9174-9188. PubMed ID: 27999187
[TBL] [Abstract][Full Text] [Related]
19. Influence of soluble or matrix-bound isoforms of vascular endothelial growth factor-A on tumor response to vascular-targeted strategies.
Akerman S; Fisher M; Daniel RA; Lefley D; Reyes-Aldasoro CC; Lunt SJ; Harris S; Bjorndahl M; Williams LJ; Evans H; Barber PR; Prise VE; Vojnovic B; Kanthou C; Tozer GM
Int J Cancer; 2013 Dec; 133(11):2563-76. PubMed ID: 23712501
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of VEGF isoforms in mouse during development and in the adult.
Ng YS; Rohan R; Sunday ME; Demello DE; D'Amore PA
Dev Dyn; 2001 Feb; 220(2):112-21. PubMed ID: 11169844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
